Acquisition of brain mitochondria targeting compounds in Gastrodia elata and study on their neuroprotective activities
- VernacularTitle:天麻中脑线粒体靶向化合物的获取及其神经保护活性研究
- Author:
Xinglin YU
1
;
Liping YANG
1
;
Pu CHEN
1
;
Xiaohua DUAN
1
Author Information
1. Yunnan Key Laboratory of Dai and Yi Medicines，Yunnan University of Chinese Medicine，Kunming 650500，China
- Publication Type:Journal Article
- Keywords:
Gastrodia elata;
brain mitochondria;
ultrafil-tration centrifutgation;
HPLC;
targeted therapy;
neuroprotec-tion
- From:
China Pharmacy
2022;33(22):2700-2705
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE To obtain mitochondria targeting compounds from Gastrodia elata， and to study the neuroprotective activities of these compounds. METHODS The mitochondria was extracted from cerebral tissue of rats. The purity of mitochondria was evaluated with Janus green staining and neutral red staining. The activity of purified mitochondria was evaluated. The purified mitochondria was included in the control group，and the inactivated mitochondria was included in the experimental group. The ratio of the difference between the peak areas of the control group and the experimental group to the peak areas of control group（ΔP） was determined and calculated to verify the feasibility of the method for obtaining the mitochondria targeting compounds. The mitochondria targeting compounds from G. elata were obtained by ultrafiltration centrifugation-high performance liquid chromatography （HPLC） and identified， and the effects of the compounds on the acitivities of mitochondria were also detected. The neuroprotective activities of the compounds with better activities were studied with hypoxia glucose deprivation/reoxygenation （OGD/R） damaged HT22 cells. RESULTS The extracted mitochondria possessed high purity and activity. Results of feasibility validation showed that ultrafiltration centrifugation-HPLC method had recognition and separation function， and could be used to obtain compounds with mitochondria targeting function. Two mitochondria targeting compounds （p-hydroxybenzyl alcohol and p- hydroxybenzaldehyde） were obtained from G. elata； these 2 compounds could improve the activities of mitochondria in vitro， and p-hydroxybenzyl alcohol had higher activity. Results of cell experiment showed that pretreatment with p-hydroxybenzyl alcohol （25， 50， 100 μmol/L） had little effect on the survival rate of HT22 cells. Compared with the model group， p-hydroxybenzyl alcohol could reduce cell mortality of OGD/R damaged cells， improve cell morphology， increase the levels of ATP and MMP， and reduced LDH and ROS levels and MPTP openness；most of the differences were statistically significant （P＜0.05）. CONCLUSIONS Two brain mitochondria targeting compounds （p-hydroxybenzyl alcohol and p-hydroxybenzaldehyde） are obtained from G. elata，among E-mail：1047896527@qq.com which p-hydroxybenzyl alcohol has a significant protective effect against OGD/R-induced neuronal injury， possibly through mitochondria targeting therapy.
